Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination

Solicitation (Request for proposal) from Defense Health Agency. This notice has closed.

Open to all (no set-aside)Any registered business can bid, large or small.Who qualifies
  • ClosedDays left to respond
  • 37 daysThis buyer usually gives
  • 18%Notices this buyer changes
  • $2.8MTypical award from this office

What BidCamel found about this buyer

  • This office usually gives bidders 37 days to respond; this notice gives 58 days.
  • It changed 18% of its 11 notices after posting, so check for amendments before you submit.
  • It has 1 open bids right now. See them all.
  • It has made 1 awards in our records, typically $2.8M.

Companies this office paid before

  • Vascular Solutions Llc: 1 award, $2.8M total

These are past winners at this office, not the winner of this exact contract.

Key details
Solicitation number
HT9427-26-R-E020
NAICS code
541715 Guided Missiles and Space Vehicles, Their Propulsion
Size standard for this code
1,000 employees
Set-aside
Open to all (no set-aside)
Buying
Service
Place
28360, MD · Maryland bids
Posted
Sep 23, 2026
Last changed
Nov 12, 2026 (9 versions)
Contact
Contact details are on the SAM.gov notice. Open on SAM.gov

Description

This RPP is being issued by the Defense Health Agency Contracting Activity (DHACA), in support of the Defense Health Agency’s Portfolio Acquisition Executive (PAE) Medical Products (MP) Warfighter Protection (WPAC) & Acute Care Program Management Office (PMO) Care located in Frederick, Maryland at Fort Detrick. The Warfighter Protection and Acute Care Project Management Office (WPAC PMO) has a requirement for the development of a Barrier Combination product. The Barrier Combination product is defined as being composed of both a physical barrier to protect a wound and an antibacterial and/or antifungal activity released from the barrier to prevent the spread of organisms and avoid systemic infections. This RPP will result in one award to develop the Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination (BC) prototype product. The final product MUST be a combination wound treatment that includes a barrier component that is either infused or impregnated with antimicrobial and/or antifungal properties and have U.S. Food Drug Administration (FDA) approval (or clearance). The award, as a result of this RPP, will be awarded under the authority of prototype Other Transaction Authority (pOTA) 10 U.S.C. 4022. NOTE: Another amendment will be posted which will include Offeror questions and Government responses. (Amendment 0003 only extends the proposal due date). Amendment 0001 – removed alternate point of contact information under “Contract Information” on SAM.gov Amendment 0002 – revised proposal due date from: 12:00pm eastern, Friday, 23 Oct 2026 to: 12:00pm eastern Friday, 06 Nov 2026 Amendment 0003 – revised proposal due date from: 12:00pm eastern Friday, 06 Nov 2026 to: 12:00pm eastern Friday, 20 Nov 2026 Amendment 0004 – Incorporates Attachment J - Offeror questions & Government responses, Updates RPP, Attachment A – SOO, Attachment E- Draft Agreement Terms & Conditions, Attachment H – SOW Template, and adds Attachment K – CMMC Level I Self-Assessment Instructions.

Read the full notice and attachments on SAM.gov

Similar open bids

All open bids for NAICS 541715

From SAM.gov and USAspending.gov public data. BidCamel adds the buyer and award facts.